Valuation (9%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -36.53 | 21.14 |
PEG Ratio (TTM) | -0.37 | -11.00 |
P/S Ratio (TTM) | 5.38 | 5.40 |
P/B Ratio (TTM) | 6.31 | 4.61 |
P/FCF Ratio (TTM) | -112.77 | -20.42 |
Price to 5YR AVG Earnings Ratio | N/A | 26.68 |
Price to 5YR AVG FCF Ratio | N/A | 46.26 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -7.82% | 6.13% |
ROE (TTM) | -17.18% | 7.96% |
Net Profit Margin (TTM) | -14.53% | -16.36% |
ROIC 5YR AVG | N/A | 19.21% |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -2.41% | -23.06% | N/A |
Revenue | 7.15% | 61.55% | N/A |
Net Income | -3.98% | -24.81% | N/A |
Cash Flow | 29.47% | 216.62% | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.49 | 3.67 |
Quick Ratio (TTM) | 1.49 | 3.15 |
D/E Ratio (TTM) | 0.25 | 1.53 |
Interest Coverage (TTM) | -44.00 | 15.40 |
Piotroski F-Score | 3 | 5 |
Altman Z-Score | 3.06 | 17.22 |
LTL to 5YR AVG FCF | N/A | 5.49 |
Shares Outstanding Growth 5YR AVG | N/A | -1.84% |